Showing 1,561 - 1,580 results of 103,152 for search '(( e fold decrease ) OR ( 5 ((point decrease) OR (((a decrease) OR (mean decrease)))) ))', query time: 1.31s Refine Results
  1. 1561
  2. 1562
  3. 1563

    Decreased self-renewal capacity associated with senescence was prevented in human MSCs following treatment with Ki16425, an LPA<sub>1</sub>/LPA<sub>3</sub> antagonist. by Masahiko Kanehira (183764)

    Published 2012
    “…Human MSCs at passage 2 were cultured in the presence or absence of Ki16425 for the indicated days prior to cell lysis. Fold-change represents decrease in band intensity of Ki16425 treatment for 18 days compared with a control treatment for the same period of time. …”
  4. 1564
  5. 1565
  6. 1566
  7. 1567
  8. 1568
  9. 1569
  10. 1570
  11. 1571
  12. 1572
  13. 1573
  14. 1574
  15. 1575

    Modafinil treatment prevents METH-induced decrease in DAT immunoreactivity in the striatum. by Mariana Raineri (304307)

    Published 2013
    “…Average integrated density (% control) was determined in a region of interest in the dorsolateral striatum in mice (n = 5−8 sacrificed 48 hours (I) or 6 days (J) after the last METH injection. …”
  16. 1576
  17. 1577
  18. 1578
  19. 1579

    MVEC microvessel formation is restricted in hydrogels exhibiting increased stiffness or decreased concentration of adhesive peptides. by Rebecca A. Scott (488956)

    Published 2020
    “…An unpaired student’s t-test detect statistical significance, *p<0.05 for 7.5 wt% hydrogels containing 3 mM RGD relative to either (<b>A, C-F</b>) 15wt% hydrogels containing 3 mM RGD or (<b>G, I-L</b>) 7.5wt% hydrogels containing 1 mM RGD.…”
  20. 1580

    Ophthalmic administration of CXCR3 antagonist decreases intraocular pressure in a rat model of ocular hypertension. by Alexandre Denoyer (160189)

    Published 2012
    “…<p><i>(A)</i> A single administration of CXCR3 antagonist (NBI-74330, 1 µM, 100 µL) induces a transient decrease in intraocular pressure (n = 10 in each group). …”